Latest updates for Hcvtx

Fresh curated links around HCVTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial
  • CDC links hepatitis C cluster to clinic
  • Hepatitis C mainly linked to injecting drug use in Finland: THL

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 month ago

Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial

Atea Pharmaceuticals’ hepatitis C prospect has matched Gilead’s Epclusa in a phase 3 trial, keeping the biotech barreling toward a second readout for its shorter, simpler treatment...

Read source
taipeitimes.com /6 days ago

CDC links hepatitis C cluster to clinic

Read source
dailyfinland.fi /1 month ago

Hepatitis C mainly linked to injecting drug use in Finland: THL

In Finland, hepatitis C infections are mainly associated with injecting drug use, said the Finnish Institute for Health and Welfare (THL) in a press release on Tuesday. It is esti...

Read source
fiercebiotech.com /2 weeks ago

Labcorp launches new hepatitis D test to find patients with most severe form of virus

Labcorp is looking to plug the gap in hepatitis D monitoring with a new reflex testing solution to help find more patients with this form of the virus earlier.

Read source
indiatechnologynews.in /1 month ago

Care Health Insurance Urges Early Hepatitis Screening to Prevent Serious Liver Diseases

Mumbai, July 29, 2026: Viral hepatitis continues to be one of the leading causes of liver diseases and preventable deaths globally, with India accounting for a significant share of...

Read source
seekingalpha.com /1 day ago

Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Hcvtx

dailyfinland.fi

Recent coverage from public sources
Public source

indiatechnologynews.in

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

taipeitimes.com

Recent coverage from public sources
Public source